Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis have?
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis has 812 citations in the OpenAlex counts ScholarIQ stores.
When was Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis published?
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis has 2015 year in the ScholarIQ index.
What is the open-access status of Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis?
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis has bronze oa status in the ScholarIQ index.
What is the DOI of Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis?
The DOI for Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis is on the source record.
What is the PMID of Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis?
The PMID for Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis is on the source record.
What is the OpenAlex record for Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis?
The OpenAlex for Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis is on the source record.